Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Development of Ubiquitin-Independent Degraders

$8.26M USD

Funder NATIONAL CANCER INSTITUTE
Recipient Organization University of Florida
Country United States
Start Date Sep 01, 2023
End Date Aug 31, 2028
Duration 1,826 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10914808
Grant Description

Project Summary Degraders are chemical dimerizers that recruit a target protein (TP) to an E3 Ubiquitin (Ub) ligase. In favorable cases, this results in TP poly-Ubiquitylation and subsequent destruction by the proteasome. Degraders are difficult to develop because of the requirement that the degrader promote significant protein-protein interactions between

the TP and E3 Ub ligase in such a way that a TP lysine residue is placed appropriately to attack the activated Ub molecule. Here we propose to develop a new class of degraders that will recruit TP directly to the proteasome. We anticipate that this mechanism of action will result in potent TP destruction without the need for Ubiquitylation, which, in

turn, will make the development of these degraders far more straightforward.

All Grantees

University of Florida

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant